
This study investigates the connection between circulating β‐hydroxybutyric acid (βOHB) and diabetic kidney disease (DKD) risk in type 2 diabetes patients. The research uncovers a J-shaped association, indicating the optimal βOHB concentration range (0.12‐0.30 mM) linked to reduced DKD risk.
Like
Save
Share